Finkelstein J A, Davis R L, Dowell S F, Metlay J P, Soumerai S B, Rifas-Shiman S L, Higham M, Miller Z, Miroshnik I, Pedan A, Platt R
Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, Massachusetts, USA.
Pediatrics. 2001 Jul;108(1):1-7. doi: 10.1542/peds.108.1.1.
To test whether an educational outreach intervention for families and physicians, based on the Centers for Disease Control and Prevention (CDC) principles of judicious antibiotic use, decreases antimicrobial drug prescribing for children younger than 6 years old. Setting. Twelve practices affiliated with 2 managed care organizations (MCOs) in eastern Massachusetts and northwest Washington State. Patients. All enrolled children younger than 6 years old.
Practices stratified by MCO and size were randomized to intervention or control groups. The intervention included 2 meetings of the practice with a physician peer leader, using CDC-endorsed summaries of judicious prescribing recommendations; feedback on previous prescribing rates were also provided. Parents were mailed a CDC brochure on antibiotic use, and supporting materials were displayed in waiting rooms. Automated enrollment, ambulatory visit, and pharmacy claims were used to determine rates of antibiotic courses dispensed (antibiotics/person-year) during baseline (1996-1997) and intervention (1997-1998) years. The primary analysis (for children 3 to <36 months and 36 to <72 months) assessed the impact of the intervention among children during the intervention year, controlling for covariates including patient age and baseline prescription rate. Confirmatory analyses at the practice level were also performed.
The practices cared for 14 468 and 13 460 children in the 2 study years, respectively; 8815 children contributed data in both years. Sixty-two percent of antibiotic courses were dispensed for otitis media, 6.5% for pharyngitis, 6.3% for sinusitis, and 9.2% for colds and bronchitis. Antibiotic dispensing for children 3 to <36 months old decreased 0.41 antibiotics per person-year (18.6%) in intervention compared with 0.33 (11.5%) in control practices. Among children 36 to <72 months old, the rate decreased by 0.21 antibiotics per person-year (15%) in intervention and 0.17 (9.8%) in control practices. Multivariate analysis showed an adjusted intervention effect of 16% in the younger and 12% in the older age groups. The direction and approximate magnitude of effect were confirmed in practice-level analyses.
A limited simultaneous educational outreach intervention for parents and providers reduced antibiotic use among children in primary care practices, even in the setting of substantial secular trends toward decreased prescribing. Future efforts to promote judicious prescribing should continue to build on growing public awareness of antibiotic overuse.
基于美国疾病控制与预防中心(CDC)合理使用抗生素的原则,测试针对家庭和医生的教育推广干预措施是否能减少6岁以下儿童的抗菌药物处方量。研究地点。与马萨诸塞州东部和华盛顿州西北部的2个管理式医疗组织(MCO)相关联的12家医疗机构。患者。所有登记在册的6岁以下儿童。
按MCO和规模分层的医疗机构被随机分为干预组或对照组。干预措施包括医疗机构与一名医生同行领导者举行2次会议,使用CDC认可的合理处方建议摘要;还提供了此前处方率的反馈。向家长邮寄了一份关于抗生素使用的CDC宣传册,并在候诊室展示了相关支持材料。利用自动登记、门诊就诊和药房报销数据来确定基线期(1996 - 1997年)和干预期(1997 - 1998年)抗生素疗程的发放率(抗生素/人年)。主要分析(针对3至<36个月和36至<72个月的儿童)评估了干预措施在干预年对儿童的影响,并控制了包括患者年龄和基线处方率在内的协变量。还在医疗机构层面进行了验证性分析。
在这2个研究年度中,这些医疗机构分别照料了14468名和13460名儿童;8815名儿童在这两年都提供了数据。62%的抗生素疗程是用于治疗中耳炎,6.5%用于咽炎,6.3%用于鼻窦炎,9.2%用于感冒和支气管炎。与对照组医疗机构相比,干预组中3至<36个月大的儿童抗生素发放量每人年减少了0.41剂(18.6%),而对照组减少了0.33剂(11.5%)。在36至<72个月大的儿童中,干预组抗生素发放率每人年下降了0.21剂(15%),对照组下降了0.17剂(9.8%)。多变量分析显示,在较年幼年龄组调整后的干预效果为16%,较年长年龄组为12%。在医疗机构层面的分析中证实了效果的方向和大致幅度。
对家长和医疗服务提供者同时进行的有限教育推广干预措施减少了基层医疗中儿童的抗生素使用,即使在处方量呈大幅长期下降趋势的情况下也是如此。未来促进合理处方的努力应继续基于公众对抗生素过度使用认识的不断提高。